COMPARATIVE EVALUATION OF EFFICACY AND SAFETY OF INTRAVENOUS FERRIC CARBOXYMALTOSE VERSUS IRON SUCROSE COMPLEX FOR THE TREATMENT OF MODERATE GRADE ANEMIA IN POST CAESAREAN SECTION WOMEN: A RANDOMIZED AND PROSPECTIVE STUDY
Keywords:Iron deficiency anemia, Postpartum anemia, Iron sucrose complex, Ferric carboxymaltose
Objective: Iron deficiency anemia is common in postpartum women in India. The present study is aimed at comparing the safety and efficacy of
intravenous ferric carboxymaltose (FCM) with intravenous iron sucrose complex (ISC) in patients who underwent cesarean section and having
moderate grade anemia in postpartum period.
Methods: A prospective and comparative study was carried out in 100 post-cesarean section women with moderate grade anemia hemoglobin (Hb
7–9 g%) in Gajra Raja Medical College, Gwalior (M.P.) from February 2019 to August 2020. Subjects were randomly allocated to two groups, namely,
FCM and ICS, 50 patients in each group. In group FCM, patients were infused with 1000 mg of FCM in a single dose on 4th post-operative day. Patients in
ISC group were infused with ISC 200 mg in 100 mL normal saline on 3 alternate days on 4th, 6th, and 8th post-operative day. Mean, Hb mean corpuscular
volume (MCV), mean corpuscular Hb (MCH), and MCH concentration (MCHC) were recorded before start of therapy and 15 days after treatment in all
study subjects. Mean reticulocyte count was recorded before start of treatment and 2 days after completion of treatment that is on 6th and 10th post
cesarean day in FCM and ICS group, respectively. Adverse drug reactions were recorded during the study period. Statistical analysis was done using
Statistical Package for the Social Sciences software.
Results: Mean Hb increased by 27% in FCM and by 19% in ISC group and is significant (*p<0.05) from baseline values. FCM showed significantly
(**p<0.01) better response, than ISC group. Mean reticulocyte percent showed significant increase by 120% and 73% in FCM and ISC group,
respectively, from the baseline and change in mean reticulocyte in FCM was significant (***p<0.001) as compared to ISC. The mean rise in MCV was
12% and 5% and MCH was by 10% and 1% in FCM and ISC group, respectively. FCM groups showed significantly better response (p<0.05) than ISC.
However, in MCHC, there were 7% and 4% increase in FCM and ISC group, respectively, and on inter group comparison was not significant (p>0.05).
Adverse effects noted during the study were mild and responded to symptomatic treatment. Sixteen percentage of FCM cases and 26% of ISC cases
underwent adverse drug reactions that included nausea, vomiting, giddiness, and injection site reactions.
Conclusion: FCM is more efficacious and safer than ISC, making it the first line of management in postpartum iron deficiency anemia.
Somdatta P, ReddiahaVP, Singh B. Prevalence of anemia in postpartum period: A study of North Indian village. Trop Doct 2009;39:211-5. doi: 10.1258/td.2009.080347, PMID: 19762572
Sharma N, Thiek JL, Natung T, Ahanthem SS. Comparative study of efficacy and safety of ferric carboxy maltose versus iron sucrose in post-partum anaemia. J Obstet Gynaecol India 2017;67:253-7. doi: 10.1007/ s13224-017-0971-x, PMID: 28706363
Beard JL, Hendricks MK, Perez EM, Murray-Kolb LE, Berg A, Vernon- Fegans L, et al. Maternal iron deficiency affects postpartum emotion and cognition. J Nutr 2005;135:267-72. doi: 10.1093/jn/135.2.267, PMID: 15671224
Rogozińska E, Daru J, Nicolaides M, Amezcua-Prieto C, Robinson S, Wang R, et al. Iron preparations for women of reproductive age with iron deficiency anaemia in pregnancy (FRIDA): A systematic review and network meta-analysis. Lancet Haematol 2021;8:e503-12. doi: 10.1016/S2352-3026(21)00137-X, PMID: 34171281
Silverstein SB, Rodgers GM. Parenteral iron therapy options. Am J Hematol 2004;76:74-8. doi:10.1002/ajh.20056
Bhandal N, Russell R. Intravenous versus oral iron therapy for postpartum anemia. BJOG Int J Obstet Gynaecol 2006;113:1248-52. doi: 10.1111/j.1471-0528.2006.01062.x, PMID: 17004982
Qassim A, Mol BW, Grivell RM, Grzeskowiak LE. Safety and efficacy of intravenous iron poly maltose, iron sucrose and ferric carboxy maltose in pregnancy: A systematic review. Aust N Z J Obstet Gynaecol 2018;58:22-9. doi: 10.1111/ajo.12695, PMID: 28921558
Khatun F, Biswas C. Comparative study of intravenous iron sucrose versus intravenous ferric carboxymaltose in the management of iron deficiency anaemia in pregnancy. Int J Reprod Contracept Obstet Gynecol 2022;11:505-12. doi:10.18203/2320-1770.ijrcog 20220179
Vijan TS, Mane S, Kumar S. Comparison of iron-sucrose with ferric carboxymaltose for treatment of postpartum iron deficiency anaemia. Int J Reprod Contracept Obstet Gynecol 2022;11:2674-9. doi:10.18203/2320-1770.ijrcog20222461
Jose A, Mahey R, Sharma JB, Bhatla N, Saxena R, Kalaivani M, Kriplani A. Comparison of ferric carboxy maltose and iron sucrose complex for treatment of iron deficiency anemia in pregnancy: A randomized controlled trial. BMC Pregnancy Childbirth 2019;19:54. doi: 10.1186/s12884-019-2200-3
Froessler B, Cocchiaro C, Saadat-Gilani K, Hodyl N, Dekker G. Intravenous iron sucrose versus oral iron ferrous sulfate for antenatal and postpartum iron deficiency anemia: A randomized trial. J Matern Fetal Neonatal Med 2013;26:654-9. doi: 10.3109/14767058.2012.746299, PMID: 23130909
Kumari S, Singh SH. Iron sucrose or ferric carboxy maltose: Comparative study for treatment of post-partum iron deficiency anemia. Int J Med Res Prof 2019;5:157-62. doi: 10.21276/ijmrp. 2019.5.1.034
Christoph P, Schuller C, Studer H, Irion O, DeTejada BM, Surbek D. Intravenous iron treatment in pregnancy: Comparison of high-dose ferric carboxy maltose vs.iron sucrose. J Perinat Med 2012;40:469-74. doi: 10.1515/jpm-2011-0231, PMID: 22945271
Garg R, Singh S, Singh S, Rajvanshi R. A comparative study to evaluate the efficacy and safety of single dose intravenous iron carboxymaltose vs multidose iron sucrose in postpartum cases of severe iron deficiency anemia. J South Asian Federation Obstet Gynecol 2015;7:18-21. doi:10.5005/jp-journals-10006-1314
Breymann C. The use of iron sucrose complex for anemia in pregnancy and the postpartum period. Semin Hematol 2006;43(Suppl 6):S28-31. doi: 0.1053/j.seminhematol.2006.08.002
Patel RM, Bhabhor MB, Pahwa NR, Ravani SR. Comparative study of efficacy and safety of intravenous ferric carboxy maltose versus iron sucrose in treatment of postpartum iron deficiency anemia Int J Reprod Contracept Obstet Gynecol 2021;10:707-10. doi:10.18203/2320-770. ijrcog20210330
Van Wyck DB, Martens MG, Seid MH, Baker JB, Mangione A. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anaemia: A randomized controlled trial. Obstet Gynecol 2007;110:267-78. doi: 10.1097/01.AOG.0000275286.03283.18, PMID: 17666600
Patel AR, Patel VS, Patel PR. A comparative study of ferric carboxymaltose and iron sucrose as a parenteral iron treatment in iron deficiency anaemia during pregnancy. Int J Reprod Contracept Obstret Gynecol 2020;9:2437-41. doi:10.18203/2320-1770.ijrcog20202325
Rathod S, Samal SK, Mahapatra PC, Samal S. Ferric carboxy maltose: A revolution in the treatment of post partum anemia in Indian women. Int J Appl Basic Med Res 2015;5:25-30. doi: 10.4103/2229-516X.149230, PMID: 25664264
Sumathy C, Arulmozhi V. Comparative study of intravenous ferric carboxymaltose and iron sucrose in the management of iron deficiency anemia. Indian J Res 2017;6:91-4.
Ikuta K, Shimura A, Terauchi M, Yoshii K, Kawabata Y. Pharmacokinetics, pharmacodynamics, safety, and tolerability of intravenous ferric carboxy maltose: A dose-escalation study in Japanese volunteers with iron-deficiency anemia. Int J Hematol 2018;107:519-27. doi: 10.1007/s12185-018-2400-z, PMID: 29357079
Seid MH, Derman RJ, Baker JB, Banach W, Goldberg C, Rogers R. Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anaemia: A randomized controlled clinical trial. Am J Obstet Gynaecol 2008;199:435-7. doi: 10.1016/j.ajog.2008.07.046, PMID: 18928998
Thanusubramanian H, Patil N, Shenoy S, Bairy KL, Sarma Y. Adverse reactions of ferric carboxy maltose. J Clin Diagn Res 2014;8:HD01-2. doi: 10.7860/JCDR/2014/9499.5015, PMID: 25478369
Sridhara S, Vilakkathala R, Prabhu R, Saraf K. Delayed hypersensitivity with ferric carboxymaltose. J Clin Diagn Res 2017;11:FD01-2. doi: 10.7860/JCDR/2017/25908.10827
How to Cite
Copyright (c) 2022 Saroj Kothari, Dr. Shiralee Runwal
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.